24 Şubat 2012 Cuma
Qnexa: Qnexa Ruling Renews Debate About Its Risks and Benefits
This is why the news that Vivus is attempting to gain FDA approval for Qnexa again, has many people, in desperate need of an alternative treatment, anxiously awaiting the results. Two years ago Qnexa was rejected by the Food and Drug Administration inA new diet drug is closer to being approved by the Food and Drug Administration, but serious side effects like possible birth defects are raising concerns.SILVER SPRING, Md., (Indiana's NewsCenter)--- A panel of medical experts have voted
Kaydol:
Kayıt Yorumları (Atom)
Hiç yorum yok:
Yorum Gönder